TheHill’s Challenge Awards (Deadline 2 June)

2nd June 2022 @ 8:00 am - 5:00 pm
Loading Events

« All Events

  • This event has passed.

i4i Challenge Awards support market-ready innovations by addressing the translational gap between the clinical evaluation of technologies and their adoption, by funding the assessment of MedTech innovations in real-world healthcare settings. The expected output is a disruptive medical device or in vitro diagnostic test that can offer improved outcomes for NHS patients. There is no upper funding limit for the Challenge Awards, but costs must be fully justified.

Key eligibility criteria

Projects can be led by SMEs, NHS providers or higher education institutions (HEIs).
A minimum of two organisations must be involved and at least one of the collaborators must be from an NHS provider (e.g. an NHS Trust).
Technologies must have demonstrated safety and efficacy and must have obtained or be in the process of obtaining CE marking.
Project timelines can vary based on the required evidence for potential healthcare uptake and patient benefit. They can last up to 3 years, but a duration of up to 5 years will be considered if a longer period is needed to demonstrate long-term outcomes and a strong case is made.
Lead applicants must be based in England.

Deadline for the call: 2nd of June 2022

Deadline for the request for support to TheHill: 3rd of May 2022


2nd June 2022
8:00 am - 5:00 pm
Event Category:
Book now



Latest news

Alexander Brunner & Khansa Maria, co-founders of appliqué

Alexander Brunner & Khansa Maria, co-founders of appliqué

Through appliqué, we hope to combine our external and internal goals to generate purpose-led change throughout the startup journey. Learn more

Timon Gregg, REV

Timon Gregg, REV

Timon is the commercial lead at REV, an early stage startup, that works on enabling the future of product demos in E-commerce. Learn more

Alice Evans, AENOX Pathology

Alice Evans, AENOX Pathology

Alice is a current PhD student working with live patient tumour samples to help improve how we test new therapies for pancreatic cancer. Learn more

Rebecca Gorman, founder of Aligned AI

Rebecca Gorman, founder of Aligned AI

Rebecca Gorman, Founder and CEO at Aligned AI, is an expert in near-term AI threats, focusing on the interface between technology and human behaviour. Learn more

Enterprising Oxford

Tell us a bit about yourself and see information and resources relevant to your needs.

Get in touch

4 + 7 =

Copyright © 2022 EnSpire Oxford | Site by Herd